Torrent Pharmaceuticals

TORNTPHARM · NSE · INR

₹ 4.767,30Variação em relação ao fechamento anterior: −0,68%Variação absoluta: −₹ 32,70

Fechamento · 1 de outubro de 2026

Perfil da empresa

Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.

Descrição disponível em inglês.

Dados da empresa

Setor
Saúde
Indústria
Drug Manufacturers - Specialty & Generic
País
Índia
Sede
Avirat, Thaltej Shilaj Road, 380059, Ahmedabad
Funcionários
18.258
Listagem
TORNTPHARM · NSE
Moeda
INR
ISIN
INE685A01028